Files
Abstract
Prostate-specific antigen (PSA)-based prostate cancer screening recommendations are going through drastic changes. The U.S. Preventive Task Services 2017 (current draft recommendation), American Cancer Society 2016, and National Comprehensive Cancer Network 2016 have updated their recommendations to include a shared decision-making (SDM) process for men when they are considering PSA testing. To ensure that the recommendations are followed in clinical practice, patient decision aids (PSA-PtDAs) are one strategy to support SDM. However, the effect of the PSA-PtDAs on men's intention to undergo PSA testing remains unclear. The purpose of this systematic review and meta-analysis was to answer the following key questions: (1) how do PSA-PtDAs compared with usual care affect men's prostate cancer screening behavior and (2) are computer-based interactive PSA-PtDAs more influential in changing men's screening intention than other types of decision aids?